Navigation Links
NOVAVAX Reports Fourth Quarter and 2009 Year-End Financial Results
Date:3/12/2010

technology.  The company produces potent VLP-based recombinant vaccines utilizing new and efficient manufacturing approaches.  Novavax is committed to using its VLP technology to create country-specific vaccine solutions.  The company has formed a joint venture with Cadila Pharmaceuticals, named CPL Biologicals, to develop and manufacture vaccines, biological therapeutics and diagnostics in India.  Additional information about Novavax is available on the company's website: www.novavax.com.

Forward Looking Statements

Statements herein relating to future financial or business performance, conditions or strategies and other financial and business matters, including expectations regarding revenue, operating expenses, use of cash, and clinical developments and anticipated milestones, including a BARDA contract, Phase III studies and seeking approval in Mexico, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act. Novavax cautions that these forward-looking statements are subject to numerous assumptions, risks and uncertainties, which change over time.  Factors that may cause actual results to differ materially from the results discussed in the forward-looking statements or historical experienc
'/>"/>

SOURCE Novavax, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. NOVAVAX to Present at 22nd Annual ROTH OC Growth Stock Conference
2. NOVAVAX to Present at Cowen and Companys 30th Annual Health Care Conference
3. NOVAVAX Reports Additional Positive Data from Its Trivalent Seasonal Influenza (VLP) Vaccine Clinical Study in Healthy Adults
4. Novavax Terminates Negotiations with ROVI Pharmaceuticals for Influenza Vaccine Collaboration
5. NOVAVAX Announces Closing of Public Offering of 6,800,000 Shares of Common Stock
6. NOVAVAX Reports Positive Clinical Results from Pivotal Study of H1N1 Influenza Vaccine in Mexico
7. Novavax to Present at 8th Annual BIO Investor Forum 2009
8. Novavax Launches Pivotal Clinical Study of Novel 2009 H1N1 VLP Flu Vaccine in Mexico
9. NOVAVAX Achieves Pandemic H1N1 Influenza Production Milestone
10. Novavax Completes Enrollment of Its Second Phase II Seasonal Influenza VLP Vaccine Clinical Trial
11. Novavax Reports Positive Preclinical Results for a Novel, Broadly Cross-Protective H5N1 Pandemic Influenza Virus-like Particle (VLP) Vaccine Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2015)... April 2015 Hospira, Inc. ... Entwicklung von Biosimilar-Behandlungen, sprach heute auf der jährlichen ... (EGA) in London über ... Verfügbarkeit von Biosimilars für Patienten. Das ... Papers mit dem Titel „Why extrapolation is ...
(Date:4/24/2015)... 2015  Perrigo Company plc ("Perrigo" or the "Company") ... unsolicited offer from Mylan NV ("Mylan") (NASDAQ: MYL ... Perrigo for $60.00 per share in cash and 2.2 ... "Offer").  The Board previously concluded that ... the Company and its future growth prospects and was ...
(Date:4/24/2015)... HILL, N.C. , April 24, 2015 /PRNewswire/ ... the ability of consumers to educate themselves about ... expanded the tools and techniques available to market ... Given the changing consumer marketplace, it,s imperative that ... approaches to better identify market opportunities, niches and ...
Breaking Medicine Technology:Führungskräfte von Hospira präsentieren auf bedeutendem europäischen Biosimilars-Forum - Ankündigung eines White Papers über Extrapolation 2Führungskräfte von Hospira präsentieren auf bedeutendem europäischen Biosimilars-Forum - Ankündigung eines White Papers über Extrapolation 3Führungskräfte von Hospira präsentieren auf bedeutendem europäischen Biosimilars-Forum - Ankündigung eines White Papers über Extrapolation 4Führungskräfte von Hospira präsentieren auf bedeutendem europäischen Biosimilars-Forum - Ankündigung eines White Papers über Extrapolation 5Führungskräfte von Hospira präsentieren auf bedeutendem europäischen Biosimilars-Forum - Ankündigung eines White Papers über Extrapolation 6Führungskräfte von Hospira präsentieren auf bedeutendem europäischen Biosimilars-Forum - Ankündigung eines White Papers über Extrapolation 7Führungskräfte von Hospira präsentieren auf bedeutendem europäischen Biosimilars-Forum - Ankündigung eines White Papers über Extrapolation 8Perrigo Rejects Mylan Unsolicited Offer 2Perrigo Rejects Mylan Unsolicited Offer 3Perrigo Rejects Mylan Unsolicited Offer 4Pharmaceutical Industry Using New Technologies to Adjust Their Marketing and Research Approaches for Consumers 2
... and WALTHAM, Mass., May 25, 2011 Interleukin Genetics, Inc. ... USP Hospitales now offers the innovative Heart Health Genetic ... Hospitales, the flagship hospital in Madrid, and will soon ... identifies single nucleotide variations in two Interleukin-1 (IL-1) genes ...
... retains Adapt IP Ventures to market XDATA,s intellectual ... breast cancer detection. Over many decades, XDATA has ... automatically capturing and combining ultrasound and X-ray mammography ... patents, leading companies and research hospitals including GE, ...
Cached Medicine Technology:USP Hospitales of Spain to Offer Interleukin Genetics' Heart Health Test Throughout Its Hospital Network 2USP Hospitales of Spain to Offer Interleukin Genetics' Heart Health Test Throughout Its Hospital Network 3USP Hospitales of Spain to Offer Interleukin Genetics' Heart Health Test Throughout Its Hospital Network 4XDATA Retains Adapt IP Ventures to Market Patents and Technology for Automated 3D Ultrasound Imaging System 2
(Date:4/26/2015)... April 26, 2015 Compare-autoinsurance.org has released a ... insurance quotes . , The easiest way to find low ... have access to the best offers online, in a simple ... different providers for information about auto insurance prices. All the ... web page. , It is now possible to compare ...
(Date:4/26/2015)... 2015 A live auction will be ... from hospitals, surgery centers and other medical facilities around ... sold including radiology, surgery, endoscopy, lab, anesthesia, exam and ... place Tuesday, April 28th starting at 10:00am EDT. The ... 5025 North Hiatus Rd., Sunrise, FL 33351. Anyone ...
(Date:4/26/2015)... April 26, 2015 Forbes Living ... city is one which is synonymous with clean beaches, sparkling ... and education are major economic influencers in the city on ... dynamic talk show are pleased to announce the show will ... 26 at 3:00 PM PDT. Tune in to find out ...
(Date:4/25/2015)... Portland, ME (PRWEB) April 26, 2015 ... a Canadian based integrative healthcare event. The Integrative ... taking place October 23-24, 2015 at the Sheraton ... Healthcare Symposium Canada is one of the most ... a clinically relevant, evidenced-based CME program. The event ...
(Date:4/25/2015)... April 25, 2015 In the United ... and above needed treatment for an illicit drug ... Substance Abuse and Mental Health Services Administration’s Survey on ... these alarming numbers are harrowing stories of men and ... abuse . David H. Kerr , founder and ...
Breaking Medicine News(10 mins):Health News:Finding Low Cost Auto Insurance - An Online Guide Provides Tips 2Health News:Centurion Service Group to Auction off 1,200 Lots of Medical Equipment 2Health News:Forbes Living TV Will Air in San Diego, California 2Health News:Integrative Healthcare Event launching in Canada 2Health News:New Book Features Powerful Stories of People Who Overcame Addiction 2Health News:New Book Features Powerful Stories of People Who Overcame Addiction 3
... international team of researchers led by the University of East ... aid the early detection and diagnosis of inflammatory bowel disease. ... microscope which allows clinicians to view the bacteria that are ... disease and ulcerative colitis. "Bacteria within the wall of ...
... Dec. 4 (HealthDay News) -- Advances in the treatment ... according to two studies scheduled to be presented at ... Fla. Results from one study suggest that treating ... while another group of researchers are scheduled to report ...
... Medical Intensive Care Unit (MICU) at Vanderbilt University Medical Center for ... H1N1 flu pandemic. The tall and burly Warren County, TN, ambulance ... down and hugged some of the nurses he recognized. ... it for the next 20 days. I am just so grateful ...
... , FRIDAY, Dec. 3 (HealthDay News) -- ... cancer fell after doctors starting receiving lower Medicare payments ... patients with metastatic prostate cancer stayed steady, a new ... in the Journal of the National Cancer Institute ...
... News) -- Education and rule enforcement reduce brain and ... equipment such as headgear and mouthguards does not lower ... came to that conclusion after analyzing previous studies of ... rugby players, including six that examined the use of ...
... HealthDay Reporter , FRIDAY, Dec. 3 (HealthDay News) -- While good-looking ... may be at a disadvantage, a new study from Israel suggests. ... as likely to generate requests for an interview, the study found. ... percent less likely to get a response, whether or not the ...
Cached Medicine News:Health News:Blood Cancer Advances May Improve Survival 2Health News:Blood Cancer Advances May Improve Survival 3Health News:Over-reactive immune system kills young adults during pandemic flu 2Health News:Over-reactive immune system kills young adults during pandemic flu 3Health News:Over-reactive immune system kills young adults during pandemic flu 4Health News:Medicare Cuts May Have Spurred Drop in Prostate Cancer Treatment 2Health News:Good Looks May Help Land the Interview -- for Men 2Health News:Good Looks May Help Land the Interview -- for Men 3
Straight shafts 4 mm platform. Wide serrated handle with dull finish. Platform angled 45 degrees....
Curved shafts with 3.5 mm angled platform and dull finish. Wide serrated handle with dull finish....
Double-ended. 10 mm sickle shaped blade. 27 mm blunt, curved double-edged blade....
Fixed smooth rod which slides on skin. Designated most popular model or size....
Medicine Products: